June 18, 2008 - New imaging software that will allow physicians to more accurately diagnose and treat heart failure patients has been licensed by Emory University to Syntermed, an Atlanta-based nuclear medicine imaging and informatics software company.

June 18, 2008 - Researchers using positron emission tomography (PET) are able to see changes in coronary blood vessels, offering hope that those at risk of cardiac deaths caused by disease in the heart’s vessels can receive earlier treatment and prolong life.

As many as 50 percent of all cardiac deaths due to disease in the heart’s vessels occur in individuals with no prior history or symptoms of heart disease. In addition, standard coronary risk factors may fail to explain up to 50 percent of cardiovascular events.

June 18, 2008 - Imaging3 developed and patented a new technology called Dominion that utilizes high-resolution photo-fluoroscopy to produce three-dimensional medical diagnostic images in real- time, reportedly allowing them to be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body.

June 18, 2008 - NeoMend Inc. today said its ProGEL Surgical Sealant received a recommendation for approval from the FDA’s Anesthesiology and Respiratory Therapy Devices Advisory Panel.

The panel’s recommendation will be considered by the FDA during completion of its review of the premarket approval for ProGEL. The panel’s recommendation for FDA approval was conditioned principally on NeoMend conducting a post approval study to gather more safety data.

June 18, 2008 – Biotronik GmbH launched the Lumax 540 series, which includes implantable cardioverter defibrillators (ICDs) and a cardiac resynchronization therapy defibrillator (CRT-D), which is used with Biotronik Home Monitoring to enable continuous automatic daily data transmission of the patient’s cardiovascular status.

June 17, 2008 - The FDA has cleared Medtronic Attain StarFix OTW (over-the-wire) lead (Model 4195), an active fixation left-heart lead for cardiac resynchronization therapy (CRT).

The Attain StarFix lead, according to the manufacturer, overall, including the acute dislodgements at one day post-implant, has had a low 0.7 percent dislodgement rate. These dislodgement rates are supported by one of the industry’s largest and longest-running left-heart lead clinical studies involving 385 implants followed for up to four years.

Toshiba America Medical Systems’ Infinix Hybrid cardiovascular X-ray imaging system will be featured in three live cases during the International Symposium on the Hybrid Approach to Congenital Heart Disease (ISHAC), June 16 – 18, 2008. In the first case, codirectors of The Heart Center at Nationwide Children’s Hospital will perform a hybrid procedure on a one day old baby with hypoplastic left heart syndrome via live simulcast using Toshiba’s Infinix Hybrid system. John P. Cheatham, M.D., director of cardiac catheterization and Interventional Therapy and Mark Galantowicz, M.D., chief of cardiothoracic surgery will complete this procedure.

June 17, 2008 - Major complications following coronary artery bypass graft (CABG) surgery, even among patients least at risk of experiencing complications, remain common and add significantly to healthcare costs, as well as diminish the benefits of surgery, according to research funded and conducted by Cardiac Data Solutions, which was published in the June 2008 Annals of Thoracic Surgery.

June 17, 2008 - Visage Imaging will present the Visage Thin Client product family featuring advanced tools for Cardiac CT and CT/MR angiography, at the 3rd Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT) 2008, to be held July 16-17 in Orlando, Florida.

June 17, 2008 - Gamma Medica-Ideas and GE Healthcare signed an agreement that GE Healthcare will be the exclusive distributor of Gamma Medica-Ideas' preclinical imaging products effective July 1, 2008, as announced at the 55th annual meeting of the Society of Nuclear Medicine. Pre-Clinical imaging plays a key role in new pharmaceutical therapeutic development by allowing researchers to visualize the structure, function and response of laboratory animals in vivo.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now